1.
|
16 p, 3.0 MB |
Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
/
Gil, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Marques-Pamies, Montserrat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Valassi, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Serra, Guillermo (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Salinas, Isabel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Xifra, Gemma (Hospital Universitari de Girona Doctor Josep Trueta) ;
Casano-Sancho, Paula (Hospital Sant Joan de Déu (Manresa)) ;
Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Biagetti, Betina (Hospital Universitari Vall d'Hebron) ;
Sesmilo, Gemma (Hospital Universitari Dexeus (Barcelona, Catalunya)) ;
Marcos-Ruiz, Jennifer (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodriguez-Lloveras, Helena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rueda-Pujol, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aulinas, Anna (Institut d'Investigació Biomèdica Sant Pau) ;
Blanco, Alberto (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Hostalot, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Simó-Servat, Andreu (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Muñoz, Fernando (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Rico, Marta (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Ibáñez-Domínguez, Javier (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Cordero Asanza, Esteban (Hospital Universitari Vall d'Hebron) ;
Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ;
Jordà, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Different medical therapies have been developed for pituitary adenomas. However, Non-Functioning Pituitary Neuroendocrine Tumors (NF-PitNET) have shown little response to them. Furthermore, epithelial-mesenchymal transition (EMT) has been linked to resistance to medical treatment in a significant number of tumors, including pituitary adenomas. [...]
2023 - 10.3389/fendo.2023.1129213
Frontiers in Endocrinology, Vol. 14 (march 2023)
|
|
2.
|
14 p, 3.9 MB |
Combined analysis of miR-200 family and its significance for breast cancer
/
Fontana, Andrea (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Barbano, Raffaela (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Dama, Elisa (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Pasculli, Barbara (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Rendina, Michelina (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Morritti, Maria Grazia (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Melocchi, Valentina (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Castelvetere, Marina (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Valori, Vanna Maria (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Ravaioli, Sara (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS) ;
Bravaccini, Sara (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS) ;
Ciuffreda, Luigi (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Graziano, Paolo (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Maiello, Evaristo (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Copetti, Massimiliano (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Fazio, Vito Michele (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Bianchi, Fabrizio (Fondazione IRCCS Casa Sollievo della Sofferenza) ;
Parrella, Paola (Fondazione IRCCS Casa Sollievo della Sofferenza)
While the molecular functions of miR-200 family have been deeply investigated, a role for these miRNAs as breast cancer biomarkers remains largely unexplored. In the attempt to clarify this, we profiled the miR-200 family members expression in a large cohort of breast cancer cases with a long follow-up (H-CSS cohort) and in TCGA-BRCA cohort. [...]
2021 - 10.1038/s41598-021-82286-1
Scientific reports, Vol. 11 Núm. 1 (december 2021) , p. 2980
|
|
3.
|
17 p, 24.9 MB |
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
/
Gil, Joan (Institut d'Investigació Biomèdica Sant Pau) ;
Marques-Pamies, Montserrat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Valassi, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
García-Martínez, Araceli (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Serra, Guillermo (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Hostalot, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fajardo-Montañana, Carmen (Hospital Universitari de la Ribera (València)) ;
Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bernabeu Morón, Ignacio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Marazuela, Mónica (Hospital Universitario de la Princesa (Madrid)) ;
Rodríguez-Lloveras, Helena (Institut Germans Trias i Pujol) ;
Cámara, Rosa (Hospital Universitari i Politècnic La Fe (València)) ;
Salinas, Isabel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Lamas, Cristina (Complejo Hospitalario Universitario de Albacete) ;
Biagetti, Betina (Hospital Universitari Vall d'Hebron) ;
Simó-Servat, Andreu (Mútua de Terrassa) ;
Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ;
Picó Alfonso, Antonio M (Universidad de Miguel Hernández de Elche) ;
Jordà, Mireia (Institut Germans Trias i Pujol) ;
Puig Domingo, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina)
Acromegaly is caused by excess growth hormone (GH) produced by a pituitary tumor. First-generation somatostatin receptor ligands (SRLs) are the first-line treatment. Several studies have linked E-cadherin loss and epithelial-mesenchymal transition (EMT) with resistance to SRLs. [...]
2022 - 10.3390/biomedicines10020460
Biomedicines, Vol. 10 (february 2022)
|
|
4.
|
|
5.
|
16 p, 3.7 MB |
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
/
Jiménez, Natalia (Fundació Clínic per a la Recerca Biomèdica) ;
Reig, Oscar (Hospital Clínic i Provincial de Barcelona) ;
Montalbo, Ruth (Fundació Clínic per a la Recerca Biomèdica) ;
Milà-Guasch, Maria (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Nadal-Dieste, Lluis (Hospital Clínic i Provincial de Barcelona) ;
Castellano, Giancarlo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Lozano, Juan José (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Victoria, Iván (Hospital Clínic i Provincial de Barcelona) ;
Font, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodriguez-Vida, Alejo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Carles, Joan (Vall d'Hebron Institut d'Oncologia) ;
Suárez, Cristina (Vall d'Hebron Institut d'Oncologia) ;
Domènech, Montserrat (Medical Oncology Department, Fundació Althaia Manresa) ;
Sala-González, Núria (Hospital Universitari de Girona Doctor Josep Trueta) ;
Fernández, Pedro Luis (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Rodríguez-Carunchio, Leonardo (Hospital Clínic i Provincial de Barcelona) ;
Diaz, Sherley (Hospital Clínic i Provincial de Barcelona) ;
Prat, Aleix (Hospital Clínic i Provincial de Barcelona) ;
Marín-Aguilera, Mercedes (Hospital Clínic i Provincial de Barcelona) ;
Mellado, Begoña (Hospital Clínic i Provincial de Barcelona)
The prostatic tumor cells plasticity is involved in resistance to hormone-therapy, allowing these cells to survive despite androgen receptor inhibition. However, its role in taxanes resistance has not been fully established. [...]
2020 - 10.3389/fonc.2020.594023
Frontiers in Oncology, Vol. 10 (november 2020)
|
|
6.
|
18 p, 3.3 MB |
Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells
/
Gener, Petra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rafael, Diana (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ;
Seras-Franzoso, Joaquin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez Martín, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alamo Pindado, Luis (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Casas, Glòria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fernández Caparrós, Yolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Díaz Riascos, Zamira Vanessa. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Abasolo, Ibane. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Schwartz, Simó (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Therapeutic resistance seen in aggressive forms of breast cancer remains challenging for current treatments. More than half of the patients suffer from a disease relapse, most of them with distant metastases. [...]
2019 - 10.3390/cancers11081058
Cancers, Vol. 11 Núm. 8 (august 2019) , p. 1058
|
|
7.
|
9 p, 652.1 KB |
ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas
/
Castellana, Barbara (Institut d'Investigació Biomèdica Sant Pau) ;
Escuin i Borràs, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Peiró, Gloria (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
García-Valdecasas Vilanova, Bárbara (Universitat Autònoma de Barcelona) ;
Vázquez, Tania (Institut d'Investigació Biomèdica Sant Pau) ;
Pons, Cristina (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez Olabarria, Maitane (Institut d'Investigació Biomèdica Sant Pau) ;
Barnadas i Molins, Agustí (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Lerma Puertas, Enrique (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Universitat Autònoma de Barcelona
The mechanism of progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) remains largely unknown. We compared gene expression in tumors with simultaneous DCIS and IDC to decipher how diverse proteins participate in the local invasive process. [...]
2012 - 10.7150/jca.4120
Journal of Cancer, Vol. 3, Núm. 1 (2012) , p. 175-183
|
|
8.
|
16 p, 4.3 MB |
Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival
/
Vilardell, Jordi (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Alcaraz Muñoz, Estefania (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Sarró, Eduard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Trilla, Enric (Hospital Universitari Vall d'Hebron) ;
Cuadros, Thais (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torres Ramírez, Inés Ma. de (Hospital Universitari Vall d'Hebron) ;
Plana i Coll, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron) ;
Pinna, Lorenzo A. (University of Padova) ;
Ruzzene, Maria (University of Padova) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Meseguer Navarro, Anna (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Itarte, Emilio (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive subtype of renal cancer. STAT3 pathway is altered in these tumors and p-STAT3 Ser727 is an independent prognostic factor for ccRCC. [...]
2018 - 10.18632/oncotarget.23422
Oncotarget, Vol. 9, Num. 5 (January 2018) , p. 5736-5751
|
|
9.
|
9 p, 3.4 MB |
Snail1 expression is required for sarcomagenesis
/
Alba-Castellón, Lorena (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Batlle, Raquel (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Francí, Clara (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Fernández-Aceñero, María J. (Hospital Universitario Fundación Jiménez Díaz) ;
Mazzolini, Rocco (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Peña, Raúl (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Loubat, Jordina (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ;
Rodríguez, Rufo (Hospital Virgen de la Salud (Toledo)) ;
Curto Navarro, Josué (Universitat Autònoma de Barcelona. Centre d'Estudis en Biofísica) ;
Albanell Mestres, Joan (Hospital del Mar (Barcelona, Catalunya)) ;
Munoz, Alberto (Instituto de Investigaciones Biomédicas "Alberto Sols") ;
Bonilla, Félix (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Ignacio Casal, J. (Consejo Superior de Investigaciones Científicas. Centro de Investigaciones Biológicas) ;
Rojo, Federico (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Garcia de Herreros, Antonio (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut)
Snail1 transcriptional repressor is a major inducer of epithelial-to mesenchymal transition but is very limitedly expressed in adult animals. We have previously demonstrated that Snail1 is required for the maintenance of mesenchymal stem cells (MSCs), preventing their premature differentiation. [...]
2014 - 10.1016/j.neo.2014.05.002
Neoplasia (New York, N.Y.), Vol. 16, Issue 5 (May 2014) , p. 413-421
|
|
10.
|
12 p, 2.2 MB |
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
/
De Mattos-Arruda, Leticia (Vall d'Hebron Institut d'Oncologia) ;
Bottai, Giulia (Oncology Experimental Therapeutics Unit. IRCCS Humanitas Clinical and Research Institute (Italy)) ;
Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ;
Di Tommaso, Luca (IRCCS Humanitas Clinical and Research Institute (Itàlia)) ;
Giovannetti, Elisa (University of Pisa. Cancer Pharmacology Laboratory. AIRC Start-Up Unit (Italy)) ;
Peg, Vicente (Hospital Universitari Vall d'Hebron) ;
Losurdo, Agnese (IRCCS Humanitas Clinical and Research Institute (Itàlia). Division of Oncology and Hematology) ;
Pérez-Garcia, José (Vall d'Hebron Institut d'Oncologia) ;
Masci, Giovanna (IRCCS Humanitas Clinical and Research Institute (Itàlia). Division of Oncology and Hematology) ;
Corsi, Fabio (University of Milan. Deparment of Clinical and Biomedical Sciences "Luigi Sacco" (Italy)) ;
Cortés, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ;
Seoane Suárez, Joan (Vall d'Hebron Institut d'Oncologia) ;
Calin, George A. (The University of Texas MD Anderson Cancer Center (USA)) ;
Santarpia, Libero (Oncology Experimental Therapeutics Unit. IRCCS Humanitas Clinical and Research Institute (Italy)) ;
Universitat Autònoma de Barcelona
Patients with primary HER2-positive breast cancer benefit from HER2-targeted therapies. Nevertheless, a significant proportion of these patients die of disease progression due to mechanisms of drug resistance. [...]
2015 - 10.18632/oncotarget.5495
Oncotarget, Vol. 6, Num. 35 (October 2015) , p. 37269-37280
|
|